Chloramphenicol and Quinupristin-dalfopristin Combination

The combination of chloramphenicol and Synercid (quinupristin-dalfopristin) is used in clinical settings for treating serious infections, particularly those caused by vancomycin-resistant Enterococcus faecium (VRE). This combination has been documented in medical literature as a treatment approach when other options have failed or when dealing with resistant organisms. **Chloramphenicol** is a broad-spectrum antibiotic that destroys bacteria by inhibiting protein synthesis. It's effective against various bacterial infections. **Synercid (quinupristin-dalfopristin)** is a streptogramin antibacterial agent administered intravenously. It consists of two semisynthetic pristinamycin derivatives: quinupristin (derived from pristinamycin I) and dalfopristin (derived from pristinamycin IIA) in a 30:70 ratio. It works by interfering with bacterial protein synthesis.